Tsuji, T., Yoshida, Y., Fujita, T., & Kohno, T. (2012). Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase‐4 inhibitor, examined in non‐obese diabetic mice. Blackwell Publishing Ltd.
Stile di citazione ChicagoTsuji, Takumi, Yuya Yoshida, Tetsuro Fujita, e Takeyuki Kohno. Oral Therapy for Type 1 Diabetes Mellitus Using a Novel Immunomodulator, FTY720 (fingolimod), in Combination With Sitagliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Examined in Non‐obese Diabetic Mice. Blackwell Publishing Ltd, 2012.
Citazione MLATsuji, Takumi, Yuya Yoshida, Tetsuro Fujita, e Takeyuki Kohno. Oral Therapy for Type 1 Diabetes Mellitus Using a Novel Immunomodulator, FTY720 (fingolimod), in Combination With Sitagliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Examined in Non‐obese Diabetic Mice. Blackwell Publishing Ltd, 2012.